Example: Heart Attack
Clinical Trials on Anaplastic Thyroid Cancer
Total 69 results
-
NCT02726503CompletedConditions: Anaplastic Thyroid Cancer
-
NCT04574817Not yet recruitingConditions: Anaplastic Thyroid Cancer
-
NCT03085056RecruitingConditions: Anaplastic Thyroid Cancer
-
NCT01774279RecruitingConditions: Anaplastic Thyroid Cancer
-
NCT02516774WithdrawnConditions: Anaplastic Thyroid Cancers
-
NCT00280852CompletedConditions: Anaplastic Thyroid Cancer
-
NCT03122496Active, not recruitingConditions: Metastatic Anaplastic Thyroid Cancer
-
NCT01701349WithdrawnConditions: Anaplastic Thyroid Cancer
-
NCT02244463RecruitingConditions: Anaplastic Thyroid Cancer; Thyroid Cancer
-
NCT03565536Unknown statusConditions: Thyroid Cancer, Anaplastic
-
NCT02688608RecruitingConditions: Anaplastic Thyroid Cancer
-
NCT00507429TerminatedConditions: Anaplastic Thyroid Cancer
-
NCT01240590CompletedConditions: Solid Tumor; Anaplastic Thyroid Cancer
-
NCT02152137Active, not recruitingConditions: Anaplastic Thyroid Cancer; Recurrent Thyroid Cancer
-
NCT02657369TerminatedConditions: Thyroid Carcinoma, Anaplastic
-
NCT04739566RecruitingConditions: Thyroid Gland Anaplastic Carcinoma
-
NCT00603941TerminatedConditions: Anaplastic Thyroid Cancer
-
NCT00126568TerminatedConditions: Anaplastic Thyroid Cancer; Recurrent Thyroid Cancer
-
NCT01236547Active, not recruitingConditions: Thyroid Gland Anaplastic Carcinoma
-
NCT04420754RecruitingConditions: Anaplastic Thyroid Cancer; Relapsed/Refractory Poorly Differentiated Thyroid Cancer
-
NCT04238624RecruitingStudy of Cemiplimab Combined With Dabrafenib and Trametinib in People With Anaplastic Thyroid CancerConditions: Anaplastic Thyroid Cancer; Thyroid Cancer; BRAF Gene Mutation; BRAF Mutation-Related Tumors
-
NCT04675710Not yet recruitingConditions: Thyroid Gland Anaplastic Carcinoma; Thyroid Gland Squamous Cell Carcinoma
-
NCT04552769RecruitingConditions: Thyroid Cancer; Anaplastic Thyroid Cancer; Undifferentiated Thyroid Cancer
-
NCT02289144WithdrawnConditions: Metastatic Anaplastic Thyroid Cancer; Locally Advanced Anaplastic, Undifferentiated Thyroid Cancer
-
NCT03975231RecruitingConditions: BRAF NP_004324.2:p.V600E; BRAF V600K Mutation Present; Thyroid Gland Anaplastic Carcinoma